EXActDNA-003 / NSABP B-64:Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Read more about this trial →← Back to available clinical trials
EXActDNA-003 / NSABP B-64:Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Read more about this trial →Using cancer cells in the blood (ctDNA) to determine the type of chemotherapy that will benefit patients who have had surgery for colon cancer
Read more about this trial →COGNITIVE TRAINING FOR CANCER RELATED COGNITIVE IMPAIRMENT IN BREAST CANCER SURVIVORS: A MULTI-CENTER RANDOMIZED DOUBLE- BLINDED CONTROLLED TRIAL
Read more about this trial →Effectiveness of Out-of-Pocket Cost COMmunication and Financial Navigation (CostCOM) in Cancer Patients
Read more about this trial →Testing the addition of the drug apalutamide to the usual hormone therapy and radiation therapy after surgery for prostate cancer
Read more about this trial →Mobile Health for Adherence in Breast Cancer Patients
Read more about this trial →SHORTER ANTHRACYCLINE-FREE CHEMO IMMUNOTHERAPY ADAPTED TO PATHOLOGICAL RESPONSE IN EARLY TRIPLE NEGATIVE BREAST CANCER (SCARLET), A RANDOMIZED PHASE III STUDY
Read more about this trial →